Home>News & Insights>Insights>April 2024 top M&A deals in emerging markets by regionApril 2024 top M&A deals in emerging markets by region EMIS Insights EMIS 19.06.2024 1 min read By EMIS DealWatch Emerging Europe Turkish real estate developer Torunlar GYO sold the Class A office building Torun Tower in Istanbul to local lender Denizbank for TYR 13.7bn (EUR 395.4mn). This transaction is the largest commercial real estate sale in Turkey to date. Completed in 2014 and located on Istanbul’s prestigious Buyukdere Caddesi, Torun Tower features 66,000 m² of office space across 39 floors. The building has served as Denizbank’s Head Office since its construction. Middle East & Africa Microsoft will invest USD 1.5bn in UAE-based AI company G42 for a minority stake. This investment aims to enhance their collaboration on advancing Microsoft AI technologies and cloud offerings in the UAE. G42, a global AI technology company with 20,000 employees, has published over 300 research papers in the past three years and operates a data center network through its joint venture with telecom e& (Khazna Data Centers). Latin America and the Caribbean Venezuelan state-owned oil company PDVSA added the La Ceiba and Tomoporro oil fields to a joint venture with Spanish oil giant Repsol, in a transaction valued at around USD 1.7bn. The agreement was finalized just before the USA reimposed sanctions on Venezuela’s oil sector. Repsol holds a 40% stake in the joint venture, with the fields expected to produce 20,000 barrels per day in the coming months, doubling Repsol’s output in Venezuela. La Ceiba and Tomoporro together contain over 5 billion barrels of oil. Emerging Asia Danish biotechnology company Genmab will acquire Chinese peer ProfoundBio for USD 1.8bn in cash, with the transaction expected to complete by mid-2024, pending customary conditions. The acquisition grants Genmab global rights to ProfoundBio’s advanced Antibody–drug conjugates (ADCs), including three clinical and several preclinical programs. This will enable Genmab to enhance its development and innovation of differentiated antibody therapies for cancer patients. Are you interested in M&A intelligence? Request a demo of our platform here Tags Emerging MarketsTop DealsRecent Posts Flows tilting towards fixed income EPFR 28.05.2026 Insights, Publications With headline inflation in the Eurozone and US hitting 31 and 35-month highs, respectively, investors found themselves revisiting the discounts Read More May 2026 | Top M&A Deals EMIS 26.05.2026 Insights Explore top M&A Deals in Emerging Markets. The month’s top 5 deals per region, ranked by deal value. Read More USA Rare Earth Strikes USD 2.8bn Deal for Brazil’s Serra Verde in Landmark Rare Earths Push EMIS 26.05.2026 Insights USA Rare Earth (USAR) has agreed to acquire Brazil’s Serra Verde Group in a transaction valued at approximately USD 2.8bn, creating what the companies describe as the first fully integrated “mine-to-magnet” rare earth platform outside Asia and marking one of the most strategically significant critical minerals deals of the year. Read More Sorry, no articles match the current filters. Sorry, no articles match the current search query.